Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer-Reference-Cited by-同舟云学术

Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer

Published:2017-07-13 Issue:8 Volume:34 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Sasaki Kinro^ORCID,Onodera Shinichi,Otsuka Kichiro,Satomura Hitoshi,Kurayama Eigo,Kubo Tsukasa,Takahashi Masakazu,Ito Jun,Nakajima Masanobu,Yamaguchi Satoru,Miyachi Kazuhito,Kato Hiroyuki

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s12032-017-0997-z/fulltext.html

Reference30 articles.

1. Kitano S, Shiraishi N. Laparoscopy-assisted distal gastrectomy with jejuna pouch interposition. Ann Surg Oncol. 2010;17:1987–8.

2. Ferlay J, Soerjomataram I, Diskshit R, et al. Cancer incidence and mortality worldwide: sources, methods, and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.

3. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

4. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortalities from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.

5. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of the mechanism for the combination of diallyl trisulfide and cisplatin against gastric cancer: a network pharmacology study and pharmacological evaluation;Frontiers in Pharmacology;2023-10-30

2. Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer;Anticancer Research;2023-05-29

3. The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study;BMC Cancer;2022-11-28

4. MiR-522-3p Targets Transcription Factor 4 to Overcome Cisplatin Resistance of Gastric Cells;Journal of Oncology;2022-09-27

5. Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study;Frontiers in Surgery;2022-05-11